v3.25.4
Summary of Significant Accounting Policies - Additional Information (Details)
3 Months Ended 6 Months Ended
Dec. 31, 2025
USD ($)
item
shares
Dec. 31, 2024
USD ($)
shares
Dec. 31, 2025
USD ($)
segment
item
shares
Dec. 31, 2024
USD ($)
shares
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Summary of Significant Accounting Policies            
Cash and cash equivalents $ 12,262,780   $ 12,262,780   $ 12,227,312  
Number of revenue streams | item 2   2      
Revenue recognized that was included in deferred revenue     $ 5,911,463 $ 4,883,268    
Deferred Revenue $ 9,916,853   9,916,853   10,702,120 $ 10,702,120
Accounts receivable 5,661,171   $ 5,661,171   7,191,234 $ 7,191,234
Operating segment | segment     1      
Reportable segment | segment     1      
Foreign currency transaction gain $ 36,112 $ 29,554 $ 18,856 $ 74,686    
Employee Stock Option            
Summary of Significant Accounting Policies            
Antidilutive securities, number | shares 744,000 2,815,282 1,001,934 2,746,043    
Restricted Common Stock            
Summary of Significant Accounting Policies            
Antidilutive securities, number | shares 894,000 1,967,561 1,272,092 1,815,711    
Maximum | Scite | Developed Technology and Customer Relationships            
Summary of Significant Accounting Policies            
Estimated average useful life     10 years      
Minimum | Scite | Developed Technology and Customer Relationships            
Summary of Significant Accounting Policies            
Estimated average useful life     3 years      
Europe financial institutions            
Summary of Significant Accounting Policies            
Cash and cash equivalents $ 645,962   $ 645,962   $ 426,658